Headline
The latest stories from AHA Today.
The Centers for Disease Control and Prevention will use American Rescue Plan Act funds to create a Center for Forecasting and Outbreak Analytics to anticipate public health threats, the agency announced.
The Health Resources and Services Administration awarded $19 million in grants through five programs to expand access to telehealth services in rural and underserved communities.
In evaluating whether to temporarily suspend survey activities if a hospital experiences a COVID-19 surge, the Centers for Medicare & Medicaid Services in June told AHA it will consider whether the hospital has notified the appropriate state public health agency and activated its emergency…
President Biden extended through Dec. 31, 2021, 100% federal reimbursement through the Federal Emergency Management Agency’s Public Assistance Program for eligible costs to safely reopen and operate certain private nonprofits in response to the COVID-19 emergency, including private nonprofit…
COVID-19 vaccine booster shots will be widely available to the American public, starting next month, according to a joint statement from Biden administration health officials.
AHA shared with the National Economic Council, Federal Trade Commission, and departments of Health and Human Services and Justice an updated study by Charles River Associates on the benefits of mergers within the hospital field.
BlackBerry announced a set of cyber vulnerabilities in its QNX Real Time Operating System for medical devices and other products, which a remote attacker could exploit to cause a denial-of-service condition or execute arbitrary code on affected devices.
The AHA has released its next People Matter, Words Matter poster, which can be downloaded, shared and hung in clinical, office or other care settings.
The American Medical Association published a Current Procedural Terminology code for providers administering a potential third dose of the Moderna COVID-19 vaccine.
Scientists at the National Institutes of Health have developed a sample preparation method to detect SARS-CoV-2 that could reduce the time and cost of COVID-19 diagnostic testing, the agency announced.